Double hit on melanoma unlocks barrier to immunotherapy

avril 2018

Researchers at EPFL and UNIL have discovered a dangerous liaison between immune cells that limits the efficacy of immunotherapy in melanoma. But they also found a way to disrupt it. The study is published in Science Translational Medicine.


octobre 2019

novembre 2018

octobre 2018

septembre 2018

novembre 2017